Edek YC, Ertürk E, Adışen E. Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. Dermatol Pract Concept. 2024;14(4):e2024252. doi:10.5826/dpc.1404a252